ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

COT Concateno

117.50
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Concateno LSE:COT London Ordinary Share GB00B06LBN62
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 117.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Inverness Medical Press Release

05/08/2009 4:44pm

UK Regulatory



 

TIDMCOT 
 
RNS Number : 9548W 
Inverness Medical Innovations, Inc 
05 August 2009 
 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR 
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE 
RELEVANT LAWS OF SUCH JURISDICTION 
 
 
FOR IMMEDIATE RELEASE 
5th AUGUST 2009 
 
 
INVERNESS MEDICAL INNOVATIONS ANNOUNCES 
OFFERING OF $150 MILLION OF SENIOR NOTES 
WALTHAM, Mass. Inverness Medical Innovations, Inc. (NYSE: IMA - News), a global 
leader in enabling individuals to take charge of their health at home through 
the merger of rapid diagnostics and health management, today announced that it 
intends to offer $150 million of senior notes due 2016 in a public offering. 
Further information can be found at - 
http://www.sec.gov/Archives/edgar/data/1145460/000095012309029635/b76664aiexv99 
1.htm 
About Inverness Medical Innovations, Inc. 
By developing new capabilities in near-patient diagnosis, monitoring and health 
management, Inverness Medical Innovations enables individuals to take charge of 
improving their health and quality of life at home. Inverness' global leading 
products and services, as well as its new product development efforts, focus on 
infectious disease, cardiology, oncology, drugs of abuse and women's health. 
Inverness is headquartered in Waltham, Massachusetts. 
For additional information on Inverness Medical Innovations, please visit 
www.invmed.com. 
Enquiries: 
Inverness Medical Innovations 
Doug Guarino001 781 647 3900 
Jon Russell    001 781 647 3900 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 OUPUUUQWRUPBGAA 
 

1 Year Concateno Chart

1 Year Concateno Chart

1 Month Concateno Chart

1 Month Concateno Chart

Your Recent History

Delayed Upgrade Clock